Commencez
mooonshine199

KTRA 2x Phase two drugs data due soon.

Kintara Therapeutics, Inc. (NASDAQ:KTRA)  
mooonshine199  
NASDAQ:KTRA   Kintara Therapeutics, Inc.
Trend Analysis Fundamental Analysis
0
0
trendanalysis fundamental
100m shelf popped out of the blue, now in effect. Phase two data is due and looks to be positive. Cap is under 60m. Seems very undervalued here. The shelf is strange because the CEO has stated that they had enough cash to get through Q4/21, so why the offering now?
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.